Assessing the cost-effectiveness of treating chronic hepatitis C virus in people who inject drugs in Australia-Reference-Cited by-同舟云学术

Assessing the cost-effectiveness of treating chronic hepatitis C virus in people who inject drugs in Australia

Published:2013-03-25 Issue:4 Volume:28 Page:707-716
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Visconti Adam J¹²,Doyle Joseph S³⁴,Weir Amanda⁵,Shiell Alan M²,Hellard Margaret E⁵³⁴

Affiliation:

1. School of Medicine; University of California, San Francisco; San Francisco California USA

2. The Centre of Excellence in Intervention and Prevention Science; Carlton South

3. Infectious Diseases Unit; The Alfred

4. Department of Epidemiology and Preventative Medicine; Monash University; Melbourne Victoria Australia

5. Centre for Population Health; Burnet Institute

Funder

University of California, San Francisco's Research Allocation Program for Trainees

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12041/fullpdf

Reference43 articles.

1. Modeling the hepatitis C virus epidemic in Australia;Razali;Drug Alcohol Depend.,2007

2. Australian Department of Health Economic Evaluation of Hepatitis C in Australia 2005 http://www.health.gov.au/internet/main/publishing.nsf/Content/phd-hepc-econeval

3. Estimating future hepatitis C morbidity, mortality, and costs in the United States;Wong;Am. J. Public Health,2000

4. Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment;Spiegel;Hepatology,2005

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Supporting direct acting antiviral medication adherence and treatment completion in a sample of predominantly rural veterans with hepatitis C and substance use disorders;Addiction Science & Clinical Practice;2024-06-25

3. Health-related quality of life among people who inject drugs in Australia;Quality of Life Research;2023-06-23

4. Cost-effectiveness analysis of an outreach model of Hepatitis C Virus (HCV) assessment to facilitate HCV treatment in primary care;PLOS ONE;2020-06-17

5. Economic Evaluation of Hepatitis C Treatment Extension to Acute Infection and Early-Stage Fibrosis Among Patients Who Inject Drugs in Developing Countries: A Case of China;International Journal of Environmental Research and Public Health;2020-01-28